Patent Assignment
Reel/Frame 016105/0488
Security Agreement
Recorded: 2004-12-21
Received: 2004-12-28
Pages: 9
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2004-12-21
Assignee
DRUG ROYALTY USA, INC.
ROYAL BANK PLAZA, SUITE 3120, SOUTH TOWER, BOX 122, 200 BAY STREET, TORONTO, ONTARIO, CAX, M5J 2J3, CANADA
Covered Properties
(18)
Oligonucleotide Synthesis with Alternative Solvents
Application:
10/858,917 →
Hub Motor Mechanism
Application:
10/775,109 →
Process for the Synthesis of Oligomeric Compounds
Application:
10/760,940 →
Derivatized Oligonucleotides Having Improved Uptake and Other Properties
Application:
10/755,166 →
wavelength locker with liquid crystal tunable filter generating transmitted and reflected outputs
Application:
10/719,078 →
Methods for Detection of Chloral Hydrate in Dichloroacetic Acid
Application:
10/679,805 →
Narrow Band Tunable Filter with Integrated Detector
Application:
10/453,455 →
Chloral-Free Dca in Oligonucleotide Synthesis
Application:
10/403,692 →
Liquid Crystal Optical Processing Systems
Application:
10/394,400 →
Multi-Pixel Liquid Crystal Cell Array
Application:
10/391,510 →
Liquid Crystal Variable Optical Attenuator
Application:
10/379,384 →
Liquid Crystal Cell Platform
Application:
10/371,235 →
Thermal Control System for Liquid Crystal Cell
Application:
10/371,983 →
Fabrication Method for Liquid Crystal Cell
Application:
10/371,976 →
2' -modified oligonucleotides
Application:
10/352,586 →
Biaxially Textured Articles Formed by Powder Metallurgy
Application:
10/232,181 →
Methods for Detection of Chloral Hydrate in Dichloroacetic Acid
Application:
10/059,776 →
Sugar Modified Oligonucleotides
Application:
09/996,263 →